Murphy & Mullick Capital Management Corp Bausch Health Companies Inc. Transaction History
Murphy & Mullick Capital Management Corp
- $123 Billion
- Q2 2025
A detailed history of Murphy & Mullick Capital Management Corp transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 100 shares of BHC stock, worth $702. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$702% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
253Shares Held
240MCall Options Held
2.46MPut Options Held
8.42M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$244 Million2.99% of portfolio
-
Goldentree Asset Management LP New York, NY34.3MShares$240 Million23.91% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny32.8MShares$230 Million11.35% of portfolio
-
Nomura Holdings Inc Tokyo, M021.5MShares$151 Million0.31% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$91.3 Million0.18% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.54B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...